BL, H., M, O., I, E., & K, T. (2023). High Mesothelin expression in pancreatic adenocarcinoma is associated with aggressive tumor features but not prognosis. American journal of cancer research, 13(9), 4235.
Chicago Style (17th ed.) CitationBL, Hagerty, Oshi M, Endo I, and Takabe K. "High Mesothelin Expression in Pancreatic Adenocarcinoma Is Associated with Aggressive Tumor Features but Not Prognosis." American Journal of Cancer Research 13, no. 9 (2023): 4235.
MLA (9th ed.) CitationBL, Hagerty, et al. "High Mesothelin Expression in Pancreatic Adenocarcinoma Is Associated with Aggressive Tumor Features but Not Prognosis." American Journal of Cancer Research, vol. 13, no. 9, 2023, p. 4235.
Warning: These citations may not always be 100% accurate.
